TP53 and breast cancer: While the TP53-Q331* mutation has been reported in adenosquamous carcinoma of the gallbladder and breast cancer, the precise relationship between TP53-Q331* and tumor progression, as well as its role in pathogenesis, remain unclear [47,48].